The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after ...

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

The analysis from the Urban Institute breaks down projected coverage losses across the 40 Medicaid expansion states, where ...

Panelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers ...

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the ...

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in ...

Oncologists should ask in advance about what young patients and their parents want to be told about changing prognoses, a new ...